All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.
Influenza for the USMLE Step 2 Exam
Etiology
  • Influenza Virus:
    • Caused by influenza viruses from the Orthomyxoviridae family. There are three main types:
    • Influenza A: Responsible for most seasonal epidemics and occasional pandemics. Subtypes are based on surface proteins:
    • Hemagglutinin (H): Binds to sialic acid receptors, allowing viral entry.
    • Neuraminidase (N): Facilitates viral release.
    • Influenza B: Causes seasonal outbreaks but is generally less severe than influenza A.
    • Influenza C: Causes mild illness and is less common.
  • Antigenic Drift vs. Antigenic Shift:
    • Antigenic drift: Minor mutations in surface proteins (H or N), leading to annual seasonal influenza outbreaks.
    • Antigenic shift: Major genetic reassortment, particularly in influenza A, resulting in new strains and potential pandemics.
Transmission
  • Respiratory Droplets:
    • Spread via coughing, sneezing, or talking, with transmission occurring through inhalation of droplets or touching contaminated surfaces followed by contact with the eyes, nose, or mouth.
  • Seasonality:
    • Influenza outbreaks peak in winter months in temperate regions, with increased transmission in colder weather.
Pathophysiology
  • Viral Replication:
    • The virus binds to sialic acid receptors on respiratory epithelial cells via hemagglutinin, leading to viral replication and destruction of epithelial cells. This impairs mucociliary clearance, promoting secondary infections.
Influenza viral entry
  • Immune Response:
    • Cytokines (e.g., interferons, IL-6, TNF-α) are released, leading to fever, malaise, and myalgias. The systemic response is responsible for many flu symptoms.
Clinical Features
  • Incubation Period:
    • Typically 1-4 days.
  • Systemic Symptoms:
    • Abrupt onset of high fever, severe myalgias, headache, and profound fatigue. These symptoms distinguish influenza from the common cold.
  • Respiratory Symptoms:
    • Dry cough, sore throat, and rhinorrhea. These are common and often worsen as the illness progresses.
  • Gastrointestinal Symptoms:
    • Common in children and include nausea, vomiting, and diarrhea.
Complications
  • Primary Viral Pneumonia:
    • Worsening respiratory symptoms with hypoxia and high fever. Chest X-ray shows bilateral infiltrates.
  • Secondary Bacterial Pneumonia:
    • A more common complication, typically caused by Streptococcus pneumoniae, Staphylococcus aureus, or Haemophilus influenzae. It presents with recurrent fever, productive cough, and lobar consolidation on chest X-ray.
  • Exacerbation of Chronic Conditions:
    • Influenza can worsen asthma, COPD, or cardiovascular conditions.
  • Other Complications:
    • Rare complications include myocarditis, rhabdomyolysis, and Guillain-Barré syndrome.
Diagnosis
  • Clinical Diagnosis:
    • During flu season, diagnosis is often based on the sudden onset of fever, myalgias, and respiratory symptoms.
  • Laboratory Testing:
    • Rapid influenza diagnostic tests (RIDTs): Quick results but low sensitivity.
    • RT-PCR: The gold standard, with high sensitivity and specificity, differentiating between influenza A and B.
Management
Antiviral Therapy
  • Neuraminidase Inhibitors:
    • Oseltamivir (oral) and zanamivir (inhaled) inhibit viral release and are effective against both influenza A and B. Treatment should begin within 48 hours of symptom onset to reduce illness duration and complications.
  • Baloxavir:
    • A newer antiviral, effective in a single oral dose, that inhibits viral replication by targeting the endonuclease enzyme.
Supportive Care
  • Symptomatic Treatment:
    • Antipyretics (e.g., acetaminophen) for fever and myalgias, hydration, and rest. Cough suppressants may be used if necessary.
Prevention
  • Annual Influenza Vaccine:
    • The most effective preventive measure. Available as inactivated vaccines (IIV) and live attenuated vaccines (LAIV), the vaccine is updated yearly to cover circulating strains.
    • Vaccination is recommended for all individuals ≥6 months, especially high-risk groups (e.g., elderly, pregnant women, healthcare workers).
  • Hand Hygiene:
    • Regular handwashing and alcohol-based hand sanitizers help prevent transmission.
Key Points
  • Influenza is caused by influenza A and B viruses and presents with abrupt onset of fever, myalgias, and respiratory symptoms.
  • Diagnosis is often clinical during flu season but can be confirmed by RT-PCR or RIDT.
  • Complications include primary viral pneumonia, secondary bacterial pneumonia, and exacerbation of chronic diseases.
  • Neuraminidase inhibitors (e.g., oseltamivir) or baloxavir should be started within 48 hours of symptom onset to be most effective.
  • Annual influenza vaccination is recommended for all individuals ≥6 months and is the best method of prevention.